Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Mibefradil inhibits noradrenaline release via blockade of N-type Ca2+ channels

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Caspase inhibitor reduces ischemia/reperfusion injury, attenuates apoptosis in vivo

Jan. 30, 1998

Tanabe's Tanatril receives E.U. approval

Jan. 30, 1998

Diosmetin derivatives for vascular disorders prepared at ADIR

Jan. 30, 1998

Folic acid therapy and cardiovascular risk reduction

Jan. 29, 1998

Long-term efficacy of epoprostenol for primary pulmonary hypertension

Jan. 29, 1998

Diphenylalkylamine derivative with cardioprotective properties characterized

Jan. 29, 1998

Antihypertensive efficacy described for Novartis' dual ACE/NEP inhibitor

Jan. 28, 1998

In vivo efficacy reported for angiotensin II blocker

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...